CAS: 677331-12-3
iCRT 14
CAS:677331-12-3
Formula:
C21H17N3O2S
Purity:
≥98% (HPLC)
Color and Shape:
Solid
Molecular weight:
375.4436
Ref: AN-AG00FC01
| 5mg | 148.00 € | |
| 100mg | 462.00 € | |
| 250mg | 555.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
Ref: 4Z-I-113001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 9 May 2024
iCRT 14
CAS:677331-12-3
iCRT 14 is a novel potent inhibitor of β-catenin-responsive transcription (CRT)(IC50= 40.3 nM in assays …
Formula:
C21H17N3O2S
Purity:
99.8%
Color and Shape:
Solid
Molecular weight:
375.44
Ref: TM-T4486
| 1mg | 38.00 € | |
| 5mg | 73.00 € | |
| 10mg | 113.00 € | |
| 25mg | 183.00 € | |
| 50mg | 269.00 € | |
| 100mg | 399.00 € | |
| 1ml*10 (DMSO) | 80.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
iCRT-14
Controlled ProductCAS:677331-12-3
Applications A potent inhibitor of β-catenin-responsive transcription (CRT) (IC50 = 40.3 nM in assays of …
Formula:
C21H17N3O2S
Color and Shape:
Light Yellow Solid
Molecular weight:
375.44
Ref: TR-I163900
| 10mg | 244.00 € | |
| 100mg | 1,632.00 € |
Estimated delivery in United States, on Wednesday 12 Jun 2024
iCRT-14
CAS:677331-12-3
iCRT-14 is a drug that has been shown to be effective in the treatment of …
Formula:
C21H17N3O2S
Purity:
Min. 95%
Molecular weight:
375.44 g/mol
Ref: 3D-FI24534
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024
